Deep Chand Oncology Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.60 M
as on 15-11-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.69 Cr
as on 15-11-2024
- Satisfied Charges ₹ 4.35 M
as on 15-11-2024
- Revenue 8.78%
(FY 2023)
- Profit 2.74%
(FY 2023)
- Ebitda 6.19%
(FY 2023)
- Net Worth 305.96%
(FY 2023)
- Total Assets 53.57%
(FY 2023)
About Deep Chand Oncology Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹4.69 Cr. The company has closed loans amounting to ₹4.35 M, as per Ministry of Corporate Affairs (MCA) records.
Chandan Tiwari and Vasu Garg serve as directors at the Company.
- CIN/LLPIN
U85100DL2016PTC305253
- Company No.
305253
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2016
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Deep Chand Oncology Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandan Tiwari  | Director | 01-Oct-2021 | Current |
| Vasu Garg | Director | 01-Feb-2023 | Current |
Financial Performance of Deep Chand Oncology Services.
Deep Chand Oncology Services Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.78% increase. The company also saw a slight improvement in profitability, with a 2.74% increase in profit. The company's net worth Soared by an impressive increase of 305.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deep Chand Oncology Services?
In 2023, Deep Chand Oncology Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 May 2024 | ₹2.50 M | Open |
Others Creation Date: 12 Aug 2021 | ₹4.00 Cr | Open |
Hdfc Bank Limited Creation Date: 23 Jun 2021 | ₹2.90 M | Open |
How Many Employees Work at Deep Chand Oncology Services?
Unlock and access historical data on people associated with Deep Chand Oncology Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deep Chand Oncology Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deep Chand Oncology Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
